Roche Calls For Re-Examination Of Tarceva Data By EU Authorities

by Rajshri on  September 5, 2006 at 8:00 PM Drug News
RSS Email Print This Page Comment
Roche Calls For Re-Examination Of Tarceva Data By EU Authorities
Roche Holding AG announced today that it has asked EU health authorities to re-examine data related to approving the pancreatic cancer treatment Tarceva. The European Committee for Medicinal Products for Human Use (CHMP) had recently rejected the Tarceva application.

''People with pancreatic cancer need new treatment options like Tarceva, which has been proven in clinical trials to significantly increase survival and has already been approved for this indication in the US,'' Roche said in a statement.

The Swiss company added that Tarceva was the first drug to show survival benefit in patients with the cancer.

Source: Medindia
RAS

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions
guest Monday, September 25, 2006

where i can buy tarceva tablets in macedonia? location and addres!

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive